Ophthalmic drug sustained release device
AssigneePublic University Corporation Nagoya City University
InventorTsutomu Yasukawa
Life of this patent
Estimating the term…
Abstract
An object of the present invention is to provide a sustained drug release system useful for treating eye diseases. There is provided a device for sustained release of an ophthalmic drug, comprising a drug enclosing part and an intraocular retention gas enclosing part adjacent to the drug enclosing part, the enclosing parts being provided in a hollow container having at least one opening part, wherein the drug enclosing part is isolated from the opening part by the intervention of the intraocular retention gas enclosing part.
Claims16
A device for sustained release of an ophthalmic drug, comprising a drug enclosing part and an intraocular retention gas enclosing part adjacent to the drug enclosing part, the enclosing parts being provided in a hollow container having at least one opening part,
- wherein the drug enclosing part is isolated from the opening part by intervention of the intraocular retention gas enclosing part
- wherein the intraocular retention gas is composed of sulfur hexafluoride and/or propane octafluoride.
A device for sustained release of an ophthalmic drug, comprising a plurality of units each comprising a drug enclosing part and an intraocular retention gas enclosing part adjacent to the drug enclosing part, the units being provided in a hollow container,
- wherein the plurality of units are partitioned by partition walls,
- wherein a region in which an opening part is to be formed after transplantation is provided in an outer wall part of the intraocular retention gas enclosing part of each of the units, and
- wherein the intraocular retention gas is composed of sulfur hexafluoride and/or propane octafluoride.
(canceled)
Dependencies are inferred from the claim text.